SEC Form 4 · accession 0001683168-17-002493
Avid Bioservices, Inc. · CDMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger J. Lias
Officer — President *** · Director
Period of report
Sep 25, 2017
Accepted (ET)
Sep 27, 2017 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000704562
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $3.19 | Sep 25, 2017 | A | 150,000 | A | Sep 25, 2018 | Sep 25, 2027 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1This option vests in four (4) equal annual installments over a four (4) year period beginning September 25, 2018 and each year thereafter until fully-vested.
Remarks
*** President, Avid Bioservices, Inc. (wholly-owned subsidiary of Peregrine Pharmaceuticals, Inc.)